Table 6.
Secretion at the pharyngeal Eustachian tube entrance.
Secretion | 2nd GA: Prior HA | 3rd GA: SI | 4th GA: Half-Time | 5th GA: Study End | ||||
---|---|---|---|---|---|---|---|---|
Animal | Control | Stent | Control | Stent | Control | Stent | Control | Stent |
A1 | n | n | n | n | n | n | n | n |
A2 | n | n | n | n | n | n | n | n |
A3 | n | n | n | n | n | n | n | n |
A4 | n | n | n | n | n | n | n | n |
A5 | n | n | n | n 1 | n | n | n | n |
A6 | n | n | n | a | n | n | n | n |
A7 | n | n | n | n | n | n | n | n |
A8 | n | n | n 2 | n | n | a | n | a |
SI: stent insertion; secretion score: n—normal (clear, serous); a—abnormal secretion (opaque, mucous) associated with ET lumen; 1—mucous/pus adhesion to perforated mucosa located anterior of the ET opening at the former HA injection site; 2—small bleeding after first stent insertion approach (stent was pulled out of the ET, change of stent side).